This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal

David Fromm, MD; David Kessel, PhD; John Webber, MD

Arch Surg. 1996;131(6):667-669.

Abstract
A novel approach to photodynamic therapy (PDT) involves endogenous photosensitization by the oral administration of -aminolevulinic acid (ALA), a naturally occurring substance that is the precursor of protoporphyrin IX (PpIX). A 60-year-old man with adenocarcinoma of the sigmoid colon received ALA, 60 mg/kg by mouth. Six hours later, when the plasma level of PpIX had peaked, the tumor was exposed locally to red light at 633 nm to activate PpIX. Endoscopy and biopsy findings subsequent to this treatment showed unequivocal visible changes and necrosis. Six months later, the patient again underwent successful treatment without adverse effects. This report suggests a role for PDT using endogenous photosensitization in certain circumstances involving adenocarcinoma of the large intestine.

(Arch Surg. 1996;131:667-669)

Author Affiliations
From the Departments of Surgery (Drs Fromm and Webber) and Pharmacology (Dr Kessel), Wayne State University, Detroit, Mich.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Recognition and Transport Characteristics of Nonpeptidic Compounds by Basolateral Peptide Transporter in Caco-2 Cells
Irie et al.
J. Pharmacol. Exp. Ther. 2001;298:711-717.
ABSTRACT | FULL TEXT  

Development of meta-Tetrahydroxyphenylchlorin-Monoclonal Antibody Conjugates for Photoimmunotherapy
Vrouenraets et al.
Cancer Res. 1999;59:1505-1513.
ABSTRACT | FULL TEXT